“We have colonoscopies, we have mammograms, but we have not had equivalents for most forms of heart disease,”  Pierre Elias, MD, Pathway Labs founder and CEO, explained.

One of the platform's biggest benefits is the rich clinical information it provides to all members of the care team.

TAVR was associated with early benefits for women. After five years, however, outcomes were comparable across the board.

The newly cleared software alerts clinicians when it detects a suspected vascular occlusion.

When CMS shared a list of cardiologists being targeted with a brand new payment model, the American College of Cardiology identified a long list of apparent mistakes.

Medaxiom CEO Jerry Blackwell, MD, MBA, FACC, discusses investor's interest in buying cardiology practices, noting that PE ownership remains relatively low.

ASE, ASNC and SCAI have come out against a WiSER model using AI for traditional Medicare prior authorizations.

Chair of the department of cardiothoracic surgery at Stanford University School of Medicine, and associate director of the Stanford Cardiovascular Institute, is the new 2026-27 president of the AATS.

The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.

Eight reports of major bleeding have been reported from Impella introducers, prompting the FDA early alert this week.